The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes

Por Bus, Pascal, Scharpfenecker, Marion, Van Der Wilk, Priscilla, Wolterbeek, Ron, Bruijn, Jan A., Baelde, Hans J.
Publicado no Diabetologia (2017)

Glomerular clusterin expression is increased in diabetic nephropathy and protects against oxidative stress-induced apoptosis in podocytes

Por He, Junling, Dijkstra, Kyra L., Bakker, Kim, Bus, Pascal, Bruijn, Jan A., Scharpfenecker, Marion, Baelde, Hans J.
Publicado no Sci Rep (2020)

Complement Activation in Patients With Diabetic Nephropathy

Por Bus, Pascal, Chua, Jamie S., Klessens, Céline Q.F., Zandbergen, Malu, Wolterbeek, Ron, van Kooten, Cees, Trouw, Leendert A., Bruijn, Jan A., Baelde, Hans J.
Publicado no Kidney Int Rep (2017)